Henry C. Bodenheimer

8.5k citations

83 papers · 5.7k indexed · 3 hit papers · h-index 28

Hepatology top 0.1%
- Hepatitis C virus research 35
- Liver Disease and Transplantation 25
- Liver Diseases and Immunity 13
- Hepatitis Viruses Studies and Epidemiology 7
Epidemiology top 0.5%
- Liver Disease Diagnosis and Treatment 36
- Hepatitis B Virus Studies 23
Transplantation top 2%
Rheumatology top 2%
- Systemic Lupus Erythematosus Research 5
Infectious Diseases top 5%
Surgery
- Organ Transplantation Techniques and Outcomes 5

Co-authors: Karen L. Lindsay Adrian M. Di Bisceglie W. Ray Kim Steven L. Flamm Gary L. Davis Jules L. Dienstag Robert P. Perrillo Carlo H. Tamburro
Cited by: Hepatology Epidemiology Transplantation
Partner nations: United States Australia Israel

In The Last Decade

Henry C. Bodenheimer

83 papers receiving 5.5k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2008 Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease†
1990 A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis B
1989 Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa

Peers

Countries citing papers authored by Henry C. Bodenheimer

Since Specialization

Citations

This map shows the geographic impact of Henry C. Bodenheimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry C. Bodenheimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry C. Bodenheimer more than expected).

Fields of papers citing papers by Henry C. Bodenheimer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry C. Bodenheimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry C. Bodenheimer. The network helps show where Henry C. Bodenheimer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Henry C. Bodenheimer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Henry C. Bodenheimer Line = papers co-authored together Henry C. Bodenheimer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Chun Kit Hung,Henry C. Bodenheimer	2017	23
2	The impact of race on organ donation authorization discussed in the context of liver transplantation. Henry C. Bodenheimer,Jeffrey M. Okun,Waheed Tajik,Julienne Obadia,Nikolina Icitovic,Patricia Friedmann,Emmanuel Marquez,Michael J. Goldstein	2012	10
3	Keratin 19 Demonstration of Canal of Hering Loss in Primary Biliary Cirrhosis: “Minimal Change PBC”? Fahad M. Khan,Arathi Rajendra Komarla,Paulo Giovanni L. Mendoza,Henry C. Bodenheimer,Neil D. Theise	2012	23
4	Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease†breakdown → W. Ray Kim,Steven L. Flamm,Adrian M. Di Bisceglie,Henry C. Bodenheimer	2008	658
5	Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon α‐2a plus ribavirin K. Rajender Reddy,Sugantha Govindarajan,Patrick Marcellin,David Bernstein,Jules L. Dienstag,Henry C. Bodenheimer,Jorge Rakela,Diethelm Messinger,Gabriele Schmidt,Andrew M. Ackrill,Stephanos J. Hadziyannis	2007	40
6	Evaluation of Fatigue in U.S. Patients with Primary Biliary Cirrhosis Carmen Stanca,Nancy Bach,Cynthia Krause,Nidhi Tandon,M. Freni,Julio Gutiérrez,Carol Bodian,J Varela Lopez,Paul D. Berk,Henry C. Bodenheimer,Andrea D. Branch,Joseph A. Odin	2005	44
7	The rate of treatment of chronic hepatitis C in patients co‐infected with HIV in an urban medical centre Alexander Restrepo,Timothy J. Johnson,David Widjaja,Lonny Yarmus,Kirsten Meyer,David J. Clain,Henry C. Bodenheimer,Albert D. Min	2005	38
8	Histopathology and Clinical Correlates of End-Stage Hepatitis B Cirrhosis: a Possible Mechanism to Explain the Response to Antiviral Therapy Samuel H. Sigal,Aftab Ala,K S Ivanov,Sabera Hossain,Carol Bodian,Thomas D. Schiano,Albert D. Min,Henry C. Bodenheimer,Swan N. Thung	2004	10
9	Efficacy of High-Dose Interferon in Combination With Ribavirin in Patients With Chronic Hepatitis C Resistant To Interferon Alone Albert D. Min,Jennifer Jones,Susanna Esposito,Edward Lebovics,Ira M. Jacobson,Franklin M. Klion,Ira S. Goldman,Jane M. Geders,Hillel Tobias,Carol Bodian,Henry C. Bodenheimer	2001	17
10	ABSENCE OF HEPATITIS G VIRUS WITHIN LIVER TISSUE OF PATIENTS UNDERGOING LIVER TRANSPLANTATION FOR CRYPTOGENIC CIRRHOSIS1 Thomas D. Schiano,Maria Isabel Fiel,Kenji Abe,Swan N. Thung,Henry C. Bodenheimer	1999	9
11	Low-dose aspirin therapy is associated with few side effects but does not prevent hepatic artery thrombosis in liver transplant recipients Douglas C. Wolf,M A Freni,Patrizia Boccagni,E. Mor,Lawrence Chodoff,Adrienne Birnbaum,Crystal Miller,M. E. Schwartz,Henry C. Bodenheimer	1997	27
12	Reassessing the role of medical therapy in the management of hepatic vein thrombosis Albert D. Min,Evren Atillasoy,Myron Schwartz,Michael Thiim,Charles M. Miller,Henry C. Bodenheimer	1997	28
13	Response to Higher Doses of Interferon Alfa–2B in Patients With Chronic Hepatitis C: A Randomized Multicenter Trial Karen L. Lindsay,Gerald L. Davis,Eugene R. Schiff,Henry C. Bodenheimer,L. Balart,Jules L. Dienstag,Robert P. Perrillo,Carlo H. Tamburro,J S Goff,Gregory T. Everson,M Silva,William N. Katkov,Zachary Goodman,Johnson Y.N. Lau,Geert Maertens,Jagadish Gogate,Bharati Sanghvi,J. Albrecht	1996	100
14	Electron Transport Chain Activity in Normal and Activated Rat Macrophages Jonathan S. Reichner,James A. Mulligan,Henry C. Bodenheimer	1995	5
15	Low-dose, titratable interferon alfa in decompensated liver disease caused by chronic infection with hepatitis B virus Robert Perrillo,Carlo H. Tamburro,Fredric Regenstein,Luis A. Balart,Henry C. Bodenheimer,Marcelo Silva,Eugene R. Schiff,Carol J. Bodicky,Barbara H. Miller,Cheryl Denham,Carmel Brodeur,Kathy Roach,Janice K. Albrecht	1995	132
16	Presence of hepatitis B and C viral genomes in US blood donors as detected by polymerase chain reaction amplification T. Jake Liang,Henry C. Bodenheimer,Ronald A. Yankee,Nancy V. Brown,Kenneth Tou En Chang,Jiakang Huang,Jack R. Wands	1994	41
17	RETRANSPLANTATION IN HEPATITIS B—A MULTICENTER EXPERIENCE1 Jeffrey S. Crippin,B. R.N. Foster,SHARON CARLEN,Anthony Borcich,Henry C. Bodenheimer	1994	56
18	Treatment of chronic hepatitis C with recombinant α-interferon. A multicentre randomized, controlled trial Gary L. Davis,L. Balart,Eugene R. Schiff,Karen L. Lindsay,Henry C. Bodenheimer,Robert P. Perrillo,William D. Carey,Ira M. Jacobson,John A. Payne,Jules L. Dienstag,David H. Van Thiel,Carlo H. Tamburro,Jay H. Lefkowitch,Janice K. Albrecht,Carlton Meschievitz,Terryl J. Ortego,Alexandra L. Gibas	1990	16
19	A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis Bbreakdown → Robert P. Perrillo,E. Schiff,Gerald L. Davis,Henry C. Bodenheimer,Karen L. Lindsay,John A. Payne,Jules L. Dienstag,C. O’Brien,Carlo H. Tamburro,Ira M. Jacobson,Richard E. Sampliner,David Feit,Jay H. Lefkowitch,Mary C. Kuhns,Carlton Meschievitz,Bharati Sanghvi,Janice K. Albrecht,Alexandra L. Gibas	1990	664
20	Evaluation of colchicine therapy in primary biliary cirrhosis Henry C. Bodenheimer,Fenton Schaffner,John C. Pezzullo	1988	102

About Henry C. Bodenheimer

Henry C. Bodenheimer is a scholar working on Hepatology, Transplantation and Epidemiology, having authored 83 papers that have together received 5.7k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (36 papers), Hepatitis C virus research (35 papers), Liver Disease and Transplantation (25 papers), Hepatitis B Virus Studies (23 papers), Liver Diseases and Immunity (13 papers), Hepatitis Viruses Studies and Epidemiology (7 papers), Organ Transplantation Techniques and Outcomes (5 papers) and Systemic Lupus Erythematosus Research (5 papers). The work is most often cited by research in Hepatology (4.3k citations), Epidemiology (4.1k citations) and Transplantation (129 citations). Henry C. Bodenheimer has collaborated with scholars based in United States, Australia and Israel. Frequent co-authors include Karen L. Lindsay, Adrian M. Di Bisceglie, W. Ray Kim, Steven L. Flamm, Gary L. Davis, Jules L. Dienstag, Robert P. Perrillo, Carlo H. Tamburro, Ira M. Jacobson and John A. Payne.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact